Valuation: GSK plc

Market Cap 79.81B 107B 93.39B 86.11B 151B 10,124B 154B 1,033B 400B 4,990B 400B 391B 17,277B P/E 2026 *
12.7x
P/E 2027 * 11.7x
Enterprise Value 95.24B 127B 111B 103B 180B 12,081B 184B 1,232B 477B 5,955B 477B 467B 20,617B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.59x
Free-Float
92.29%
Yield 2026 *
3.51%
Yield 2027 * 3.7%
1 day+1.01%
1 week+1.11%
Current month+1.11%
1 month+4.70%
3 months-4.44%
6 months+5.34%
Current year+9.78%
1 week 1,930
Extreme 1930
2,049
1 month 1,839
Extreme 1839
2,049
Current year 1,690
Extreme 1690
2,282
1 year 1,288.6
Extreme 1288.6047
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Executive/Senior Manager

9 0.0000%
06-08Buy

Executive/Senior Manager

9 0.0000%
05-22Buy

Executive/Senior Manager

9 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+1.11%+43.53%+52.20% 106B
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +0.88%+2.00%+28.60%+53.35% 357.3B
Weighted average by Cap. +0.31%+2.44%+41.90%+86.31%

Financials

2026 *2027 *
Net sales 33.86B 45.2B 39.62B 36.54B 64.17B 4,295B 65.27B 438B 170B 2,117B 170B 166B 7,330B 35.59B 47.51B 41.64B 38.4B 67.45B 4,514B 68.6B 461B 178B 2,225B 178B 174B 7,704B
Net income 6.47B 8.64B 7.57B 6.98B 12.27B 821B 12.48B 83.76B 32.41B 405B 32.44B 31.74B 1,401B 6.94B 9.26B 8.12B 7.49B 13.15B 880B 13.37B 89.79B 34.74B 434B 34.77B 34.02B 1,502B
Net Debt 15.43B 20.6B 18.06B 16.65B 29.24B 1,957B 29.74B 200B 77.27B 965B 77.32B 75.66B 3,340B 12.24B 16.33B 14.32B 13.2B 23.19B 1,552B 23.59B 158B 61.27B 765B 61.32B 59.99B 2,649B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
07/07/26 GBX 2,003.00 +1.01% 4,183,855
06/07/26 GBX 1,983.00 -1.59% 15,158,597
03/07/26 GBX 2,015.00 +0.55% 2,548,759
02/07/26 GBX 2,004.00 +3.83% 17,567,408
01/07/26 GBX 1,930.00 -2.57% 8,818,924
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
19.83GBP
Average target price
21.14GBP
Spread / Average Target
+6.62%

Quarterly revenue - Rate of surprise